BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27428322)

  • 1. Warfarin treatment and risk of myocardial infarction - A cohort study of patients with atrial fibrillation treated in primary health care.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Oct; 221():789-93. PubMed ID: 27428322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care.
    Wändell P; Carlsson AC; Holzmann M; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Eur J Clin Pharmacol; 2017 Feb; 73(2):215-221. PubMed ID: 27826643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin treatment and risk of stroke among primary care patients with atrial fibrillation.
    Wändell P; Carlsson AC; Holzmann MJ; Ärnlöv J; Johansson SE; Sundquist J; Sundquist K
    Scand Cardiovasc J; 2016; 50(5-6):311-316. PubMed ID: 27460750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
    J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system.
    Forslund T; Wettermark B; Wändell P; von Euler M; Hasselström J; Hjemdahl P
    Int J Cardiol; 2013 Dec; 170(2):208-14. PubMed ID: 24239153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study.
    Mochalina N; Jöud A; Carlsson M; Sandberg MEC; Själander A; Juhlin T; Svensson PJ
    Thromb Res; 2016 Apr; 140():94-99. PubMed ID: 26938155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quality of warfarin therapy and CHA2DS2-VASc score associate with the incidence of myocardial infarction and cardiovascular outcome in patients with atrial fibrillation: data from the nationwide FinWAF Registry.
    Raatikainen MJP; Penttilä T; Korhonen P; Mehtälä J; Lassila R; Lehto M
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):211-219. PubMed ID: 29514184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.
    Nilsson GH; Björholt I; Krakau I
    Fam Pract; 2004 Dec; 21(6):612-6. PubMed ID: 15465879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
    J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.
    Wändell P; Carlsson AC; Gasevic D; Wahlström L; Sundquist J; Sundquist K
    Ann Med; 2016; 48(1-2):59-66. PubMed ID: 26758363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
    J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of myocardial infarction and vascular death in elderly patients with atrial fibrillation taking anticoagulants: relation to atherosclerotic risk factors.
    Pastori D; Pignatelli P; Angelico F; Farcomeni A; Del Ben M; Vicario T; Bucci T; Raparelli V; Cangemi R; Tanzilli G; Lip GYH; Violi F
    Chest; 2015 Jun; 147(6):1644-1650. PubMed ID: 25429521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: A cohort study of patients treated in primary care in Sweden.
    Wändell P; Carlsson AC; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2016 Jan; 202():776-81. PubMed ID: 26474468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction.
    Fosbol EL; Wang TY; Li S; Piccini JP; Lopes RD; Shah B; Mills RM; Klaskala W; Alexander KP; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2012 Apr; 163(4):720-8. PubMed ID: 22520540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.
    Nilsson GH; Björholt I
    BMC Clin Pharmacol; 2004 Feb; 4():1. PubMed ID: 15028124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry.
    Subic A; Cermakova P; Religa D; Han S; von Euler M; Kåreholt I; Johnell K; Fastbom J; Bognandi L; Winblad B; Kramberger MG; Eriksdotter M; Garcia-Ptacek S
    J Alzheimers Dis; 2018; 61(3):1119-1128. PubMed ID: 29286925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.